Kailera Therapeutics, Inc. (KLRA): 3 filed Apr 16, 2026

Form type

3

Filing date

Apr 16, 2026

Accession number

0001193125-26-159772

Filer

Kailera Therapeutics, Inc. (CIK 2096997)